Hesperetin exerts apoptotic effect on A431 skin carcinoma cells by regulating mitogen activated protein kinases and cyclins

Cellular and Molecular Biology

Volumn 61, Issue 6, 2015, Pages 92-99

  Smina, T P ^a   Mohan, A ^a   Ayyappa, K A ^a   Sethuraman, S ^a   Krishnan, Uma Maheswari ^a  

^a SASTRA UNIVERSITY   (India)

Author keywords

Bax; Bcl 2; ERK; JNK; p21; p38

Indexed keywords

COMPLEMENTARY DNA; CYCLINE; HESPERETIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; ANTINEOPLASTIC AGENT; HESPERIDIN; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL SIGNALING ASSAY; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SKIN CARCINOMA; WESTERN BLOTTING; CARCINOMA; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; CELL SURVIVAL; CYCLINS; HESPERIDIN; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES; SKIN NEOPLASMS;

EID: 84962141567     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.14715/cmb/2015.61.6.12     Document Type: Article

References (54)

1. Pratheeshkumar, P., Sreekala, C., Zhang, Z., Budhraja, A., Ding, S., Son, Y., Wang, X., Hitron, A., Hyun-Jung, K., Wang, L., Lee J. and Shi, X., Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets. Anticancer Agents in Med. Chem. 2012, 12(10): 1159-84. doi: 10.2174/187152012803833035.
2. Anand, P., Kunnumakara, A. B., Sundaram, C., Harikumar, K. B., Tharakan, S. T., Lai, O. S., Sung B. and Aggarwal, B. B., Cancer is a Preventable Disease that Requires Major Lifestyle Changes. Pharm. Res. 2008, 25(9): 2097-2116. doi: 10.1007/s11095-008-9661-9.
3. Bialy, T.L., Rothe, M.J. andGrant-Kels, J.M., Dietary factors in the prevention and treatment of nonmelanoma skin cancer and melanoma. Dermatol Surg. 2002, 28(12): 1143-52. pii: dsu02114.
4. Millen, A. E., Tucker, M.A., Hartge, P., Halpern, A., Elder, D.E., Guerry, D., Holly, E.A., Sagebiel, R.W., and Potischman N., Diet and Melanoma in a Case-Control Study. Cancer Epidemiol Biomarkers Prev. 2004, 13(6): 1042-51. pii: 13/6/1042.
5. Block, G., Patterson B. and Subar, A., Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer. 1992, 18(1): 1-29. doi: 10.1080/01635589209514201.
6. Miller, A.L., Antioxidant Flavonoids: Structure, Function and Clinical Usage. Altern. Med. Rev. 1996, 1(2): 103-111.
7. Selvaraj, S., Krishnaswamy, S., Devashya, V., Sethuraman S. and Krishnan, U.M., Flavonoid-Metal Ion Complexes: A Novel Class of Therapeutic Agents. Med. Res. Rev. 2014, 34(4): 677-702. doi: 10.1002/med.21301.
8. Hirano, T., Abe, K., Gotoh M. and Oka, K., Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. Br. J. Cancer. 1995, 72: 1380-88. oid: NLM: PMC2034105.
9. Borradaile, N.M., Carroll K.K. and Kurowska, E.M., Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin. Lipids. 1999, 34: 591-98. PMID:10405973.
10. Zarebczan, B., Pinchot, S.N., Kunnimalaiyaan M. and Chen, H., Hesperetin, a potential therapy for carcinoid cancer. Am. J. Surg. 2011, 201: 329-33. doi: 10.1016/j.amjsurg.2010.08.018.
11. Choi, E.J., Hesperetin Induced G1-Phase Cell Cycle Arrest in Human Breast Cancer MCF-7 Cells: Involvement of CDK4 and p21. Nutr. Cancer. 2007, 59(1): 115-19. doi: 10.1080/01635580701419030.
12. Choi, E.J., Antioxidative effects of hesperetin against 7, 12-dimethylbenz(a)anthracene-induced oxidative stress in mice. Life. Sci. 2008, 82: 1059-64. doi: 10.1016/j.lfs.2008.03.002.
13. Kim, J.Y., Jung, K.J., Choi, J.S. and Chung, H.Y., Hesperetin: a potent antioxidant against peroxynitrite. Free Radic. Res. 2004, 38 (7): 761-69. PMID: 15453641.
14. Alshatwi, A.A., Ramesh, E., Periasamy V.S. and Subash-Babu, P., The apoptotic effect of hesperetin on human cervical cancer cells is mediated through cell cycle arrest, death receptor, and mitochondrial pathways. Fundam. Clin. Pharmacol. 2013, 27(6): 581-92. doi: 10.1111/j.1472-8206.2012.01061.x.
15. So, F.V., Guthrie, N., Chambers, A.F., Moussa M. and Carroll, K.K., Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr. Cancer. 1996, 262: 167-81. doi: 10.1080/01635589609514473.
16. Aranganathan S. and Nalini, N., Antiproliferative efficacy of hesperetin (citrus flavanoid) in 1,2-dimethylhydrazine-induced colon cancer. Phytother. Res. 2013, 27(7): 999-1005. doi: 10.1002/ptr.4826.
17. Panda, S., Non-melanoma skin cancer in India: Current scenario. Indian J. Dermatol. 2010, 55(4): 373-78. doi: 10.4103/0019-5154.74551.
18. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 1983, 65: 55-63. doi: 0022-1759(83)90303-4.
19. Franken, N.A.P., Rodermond, H.M., Stap, J., Haveman J. and Bree, C.V., Clonogenic assay of cells in vitro. Nat. Protoc. 2006, 1(5): 2315-9. doi: 10.1038/nprot.2006.339.
20. Shao, Z.H., Xie, J.T., Hoek, T.L.V., Mehendale, S., Aung, H., Li, C.Q., Qin, Y., Shumacker, P.T., Becker L.B. and Yuan, C.S., Antioxidant effects of American ginseng berry extract in cardio myocytes exposed to acute oxidant stress. Biochim. Biophys. Acta. 2004, 1670: 165-71. doi: 10.1016/j.bbagen.2003.12.001
21. Radhakrishnan, J., Kuppuswamy, A.A., Sethuraman S. and Subramanian, A., Topographic cue from electrospun scaffolds regulate myelin-related gene expressions in Schwann cells. J. Biomed. Nanotechnol. 2014, 10: 1-10. doi: http://dx.doi.org/10.1166/jbn.2015.1921.
22. LeBel, C.P., Ischiropoulos H. and Bondy, S.C., Evaluation of the probe 29,79- dichloro fluorecein as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 1992, 5: 227-31. doi: http://escholorship.org/uc/item/19r571vt.
23. Sak, K., Cytotoxicity of dietary flavonoids on different human cancer types. Pharmacogn. Rev. 2014, 8(16): 122-46. doi: 10.4103/0973-7847.134247.
24. Chiu, F.L. and Lin, J.K., Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts. Prostate. 2008, 68: 61-71. doi: 10.1002/pros.20690.
25. Wang, L., Wang, J., Fang, L., Zheng, Z., Zhi, D., Wang, S., Li, S., Ho, C.T. and Zhao, H., Anticancer activities of citrus peel polymethoxy flavones related to angiogenesis and others. Bio Med Research Int. 2014, 2014: 1-10. doi: 10.1155/2014/453972.
26. Patil, J.R., Chidambara-Murthy, K.N., Jayaprakasha, G.K., Chetti, M.B. and Patil, B.S., Bioactive compounds from Mexican lime (Citrus aurantifolia) juice induce apoptosis in human pancreatic cells. J Agric Food Chem. 2009, 57: 10933-42. doi: 10.1021/jf901718u.
27. Liu, H., Peng, H., J,i Z., Zhao, S., Zhang, Y., Wu, J., Fan, J. and Liao, J., Reactive oxygen species-mediated mitochondrial dysfunction is involved in apoptosis in human nasopharyngeal carcinoma CNE cells induced by Selaginella doederleinii extract. J. Ethnopharmacol. 2011, 138(1): 184-91. doi: 10.1016/j.jep.2011.08.072.
28. Zhang, J., Wu, D., Vikash, Song, J., Wang, J., Yi, J. andDong, W., Hesperetininduces the apoptosis of gastric cancer cells via activating mitochondrial pathway by increasing reactive oxygen species. Dig. Dis. Sci. 2015, doi: 10.1007/s10620-015-3696-7.
29. Zhang, J., Song, J., Wu, D., Wang, J. andDong, W. Hesperetin induces the apoptosis of hepatocellular carcinoma cells via mitochondrial pathway mediated by the increased intracellular reactive oxygen species, ATP and calcium. Med. Oncol. 2015, 32(4): 101. doi: 10.1007/s12032-015-0516-z.
30. Dhillon, A. S., Hagan, S., Rath O. and Kolch, W., MAP kinase signalling pathways in cancer. Oncogene. 2007, 26: 3279-90. doi: 10.1038/sj.onc.1210421.
31. Orlowski, R.Z., Small G.W. and Shi, Y.Y., Evidence that inhibition of p44/42, mitogen-activated protein kinase signalling is a factor in proteasome inhibitor-mediated apoptosis. J. Biol. Chem. 2002, 277: 27864-71. doi: 10.1074/jbc.M201519200.
32. Lavoie, J.N., L'Allemain, G., Brunet, A., Muller R. and Pouyssegur, J., Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 1996, 271: 20608-16. doi: 10.1074/jbc.271.34.20608.
33. Liu, J.J., Chao, J.R., Jiang, M.C., Ng, S.Y., Yen J. J. and Yang-Yen, H.F., Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3 T3 cells. Mol. Cell. Biol. 1995, 15: 3654-63. doi: 10.1128/MCB.15.7.3654.
34. Rastogi, N. and Mishra, D.P., Therapeutic targeting of cancer cell cycle using proteasome inhibitors. Cell Div. 2012, 7(1): 26. doi: 10.1186/1747-1028-7-26.
35. Thoms, H.C., Dunlop, M.G. and Stark, L.A. p38-Mediated Inactivation of Cyclin D1/Cyclin-Dependent Kinase 4 Stimulates Nucleolar Translocation of RelA and Apoptosis in Colorectal Cancer Cells. Cancer Res, 2007, 67(4): 1660-1669. doi: 10.1158/0008-5472.CAN-06-1038.
36. Yin, D., Zhou, H., Kumagai, T., Liu, G., Ong, J.M., Black K.L. and Koeffler, H.P., Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM). Oncogene. 2005, 24: 344-54. doi: 10.1038/sj.onc.1208225.
37. Hwang S.L. and Yen, G.C., Modulation of Akt, JNK, and p38 activation is involved in citrus flavonoid-mediated cytoprotection of PC12 cells challenged by hydrogen peroxide. J. Agric. Food Chem. 2009, 57: 2576-82. doi: 10.1021/jf8033607.
38. Masamha C.P. and Benbrook, D.M., Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells. Cancer Res. 2009, 69: 6565-72. doi: 10.1158/0008-5472.CAN-09-0913.
39. Alao, J.P., The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol. Cancer. 2007, 6: 24. doi: 10.1186/1476-4598-6-24.
40. Gartel A.L. and Tyner, A.L., The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol. Can. Ther. 2002, 1: 639-49. doi: http://mct.aacrjournals.org/content/1/8/639.
41. Nalini, N., Aranganathan S. and Kabalimurthy, J., Chemopreventive efficacy of hesperetin (citrus flavonone) against 1,2- dimethylhydrazine-induced rat colon carcinogenesis. Toxicol. Mec. Methods. 2012, 22(5): 397-408. doi:10.3109/15376516.2012.673092.
42. Ye, L., Chan, F., Chen S. and Leung, L.K., The citrus flavononehesperetin inhibits growth of aromatase-expressing MCF-7 tumor in ovariectomized athymic mice. J. Nutr. Biochem. 2012, 23(10): 1230-37. doi: 10.1016/j.jnutbio.2011.07.003.
43. Li, Y., Ahmad, A., Sarkar and F. H., ASPP and iASPP: Implication in cancer development and progression. Cell. Mol. Biol. 2015, 61(6): 2-8.
44. Masood, N., Qureshi, M. Z. and Yasmin, A., Association of NOTCH with different microRNAs in head and neck cancer. Cell. Mol. Biol. 2015, 61(6): 9-16.
45. Amirkhah, R., Farazmand, A., Irfan-Maqsood, M., Wolkenhauerand, O. and Schmitz, U., The role of microRNAs in the resistance to colorectal cancer treatments. Cell. Mol. Biol. 2015, 61(6): 17-23.
46. Wang, Z., Chen, J. and Capobianco, A. J., The Notch signaling pathway in esophageal adenocarcinoma. Cell. Mol. Biol. 2015, 61(6): 24-32.
47. Limami, Y., Pinon, A., Riaz, A. and Simon, A., TRAIL and targeting cancer cells: between promises and obstacles. Cell. Mol. Biol. 2015, 61(6): 33-38.
48. Silva Galbiatti-Dias, A. L., Pavarino, É. C., Kawasaki-Oyama, R. S., Maniglia, J. V., Maniglia, E. J. V. and Goloni Bertollo, E. M., Cancer stem cells in head and neck cancer: A Mini Review. Cell. Mol. Biol. 2015, 61(6): 39-43.
49. Musella, A., Marchetti, C., Gasparri, M. L., Salerno, L., Casorelli, A., Domenici, L., Imperiale, L., Ruscito, I., Abdul Halim, T., Palaia, I., Di Donato, V., Pecorini, F., Monti, M., Muzii, L. and Panici, P. B., PARP inhibition: A promising therapeutic target in ovarian cancer. Cell. Mol. Biol. 2015, 61(6): 44-61.
50. Attar, R., Tabassum, S., Fayyaz, S., Ahmad, M. S., Nogueira, D. R., Yaylim, I., Timirci-Kahraman, O., Kucukhuseyin, O., Cacina, C., Farooqi, A. A. and Ismail, M., Natural products are the future of anticancer therapy: Preclinical and clinical advancements of Viscum album phytometabolites. Cell. Mol. Biol. 2015, 61(6): 62-68.
51. Hsu, Y-C., Hsieh, Y-H., Liao, C-C., Chong, L-W., Lee, C-Y., Yu, Y-L. and Chou, R-H., Targeting post-translational modifications of histones for cancer therapy. Cell. Mol. Biol. 2015, 61(6): 69-84.
52. Chong, L-W., Chou, R-H., Liao, C-C., Lee, T-F., Lin, Y., Yang, K-C. and Hsu, Y-C. Saturated fatty acid induces cancer stem cell-like properties in human hepatoma cells. Cell. Mol. Biol. 2015, 61(6): 85-91.
53. Ahmadi, M., Jafari, R., Marashi, S. A. and Farazmand, A., Indirect role of microRNAs and transcription factors in the regulation of important cancer genes: A network biology approach. Cell. Mol. Biol. 2015, 61(6): 100-107.
54. Zahoor, A., Mansoor, Q., Farooqi, A. A., Fayyaz, S., Naz, G. and Ismail, M., Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and death receptor (DR4) genes contribute to susceptibility to colorectal cancer in pakistani population. Cell. Mol. Biol. 2015, 61(6): 108-112.